Wrapmanager Inc. Sells 2,734 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Wrapmanager Inc. cut its stake in shares of Definitive Healthcare Corp. (NASDAQ:DHFree Report) by 7.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 33,767 shares of the company’s stock after selling 2,734 shares during the period. Wrapmanager Inc.’s holdings in Definitive Healthcare were worth $336,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of DH. Arizona State Retirement System raised its holdings in shares of Definitive Healthcare by 13.6% in the 4th quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock valued at $142,000 after purchasing an additional 1,701 shares during the period. SG Americas Securities LLC bought a new stake in Definitive Healthcare in the third quarter valued at approximately $116,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Definitive Healthcare by 209.8% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,209 shares of the company’s stock valued at $161,000 after buying an additional 10,977 shares during the last quarter. J.P. Morgan Private Wealth Advisors LLC bought a new position in shares of Definitive Healthcare during the 3rd quarter worth approximately $131,000. Finally, Corton Capital Inc. raised its stake in Definitive Healthcare by 17.0% in the 3rd quarter. Corton Capital Inc. now owns 19,964 shares of the company’s stock valued at $160,000 after acquiring an additional 2,898 shares during the period. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Trading Down 3.4 %

Shares of DH stock traded down $0.18 during trading hours on Thursday, hitting $5.17. 3,323,524 shares of the company’s stock traded hands, compared to its average volume of 643,916. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20. Definitive Healthcare Corp. has a 12 month low of $4.38 and a 12 month high of $12.45. The stock has a market cap of $608.97 million, a PE ratio of -2.90, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. The stock’s 50 day simple moving average is $7.61 and its 200 day simple moving average is $8.27.

Definitive Healthcare (NASDAQ:DHGet Free Report) last issued its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. On average, sell-side analysts anticipate that Definitive Healthcare Corp. will post 0.11 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on DH shares. Deutsche Bank Aktiengesellschaft reduced their price objective on Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating for the company in a report on Thursday. Morgan Stanley lowered Definitive Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $11.50 to $9.00 in a report on Wednesday. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Wednesday. Stifel Nicolaus reduced their target price on shares of Definitive Healthcare from $11.00 to $9.50 and set a “buy” rating for the company in a research report on Wednesday. Finally, Canaccord Genuity Group decreased their target price on shares of Definitive Healthcare from $10.00 to $8.00 and set a “hold” rating on the stock in a research report on Wednesday. Nine research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $9.94.

Check Out Our Latest Analysis on DH

Definitive Healthcare Company Profile

(Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Read More

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.